监测超声发现的亚厘米肝结节患者肝细胞癌风险:一项系统综述
该系统综述检索2005年1月至2024年7月文献,纳入9项研究,评估肝硬化患者超声检出亚厘米结节的肝细胞癌发生风险。病灶水平合并发生比例为31.9%(95%CI 8.7%-69.7%),患者水平为21.3%(95%CI 6.0%-53.6%),但异质性高(I²>90%);2015年后开展的研究中位随访2年肝癌发生率仅约5%。
要点
- 亚厘米结节患者合并肝癌发生比例病灶水平31.9%、患者水平21.3%,异质性I²>90%。
- 2015年后研究的中位随访2年内肝癌发生率仅约5%。
- 高龄、男性、甲胎蛋白升高、血小板减少及Child Pugh B级肝硬化与肝癌发生相关。
核心结论
- 多达五分之一的亚厘米结节患者可能发生肝细胞癌,但当代队列报告的风险显著较低。
- 高龄、甲胎蛋白升高或肝功能较差的患者肝癌风险最高,凸显对更好风险分层模型的未满足需求。
研究设计与样本
- 系统综述,检索Ovid MEDLINE和EMBASE数据库2005年1月至2024年7月发表的相关文章。
- 纳入9项符合条件的研究,其中5项提供病灶和患者水平数据(n=354例患者),2项仅患者水平数据(n=888例患者),2项仅病灶水平数据(n=69个病灶)。
- 采用随机效应模型计算肝细胞癌发生的合并比例。
主要发现
- 肝细胞癌发生的合并比例在病灶水平为31.9%(95%CI 8.7%-69.7%),在患者水平为21.3%(95%CI 6.0%-53.6%)。
- 合并估计受高异质性限制(I²>90%)。
- 在2项研究期晚于2015年的研究中,中位随访2年期间仅约5%的患者发生肝细胞癌。
- 与肝细胞癌发生相关的风险因素包括高龄、男性、甲胎蛋白水平升高、血小板减少和Child Pugh B级肝硬化。
关键数值与推荐
- 指南推荐超声发现的亚厘米结节应接受短间隔监测超声随访,基于其 assumed 低肝细胞癌风险和<1 cm病灶诊断影像性能欠佳。
局限性
- 研究局限性包括样本量小、选择偏倚、肝细胞癌确认偏倚以及未报告与肝细胞癌相关的因素。
- 合并估计受高异质性限制(I²>90%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Guidelines recommend that sub-centimeter nodules on ultrasound be followed with short-interval surveillance ultrasound, given assumed low risk of hepatocellular carcinoma (HCC) and suboptimal diagnostic imaging performance in lesions <1 cm. We performed a systematic review to estimate HCC risk among patients with cirrhosis and sub-centimeter nodules detected on ultrasound. METHODS: We systematically searched Ovid MEDLINE and EMBASE databases for relevant articles published between January 2005 and July 2024. A random-effects model was used to calculate the pooled proportion of incident HCC. RESULTS: We identified 9 eligible studies, of which 5 provided both lesion- and patient-level data (n = 354 patients), 2 patient-level alone (n = 888 patients), and 2 lesion-level alone (n = 69 lesions). The pooled proportion of incident HCC was 31.9% (95% confidence interval [CI], 8.7%-69.7%) on a lesion-level and 21.3% (95% CI, 6.0%-53.6%) on a patient-level; however, pooled estimates were limited by high heterogeneity (I2 >90%). Among 2 studies with study periods post-dating 2015, HCC developed in only ∼5% of patients during a median follow-up of 2 years. Risk factors associated with incident HCC were older age, male sex, elevated alpha-fetoprotein levels, thrombocytopenia, and Child Pugh B cirrhosis. Limitations of studies included small sample sizes, selection bias, ascertainment bias for HCC, and failure to report factors associated with HCC. CONCLUSION: Up to one-fifth of patients with sub-centimeter nodules may develop HCC, although contemporary cohorts report a substantially lower risk. Older patients and those with elevated alpha-fetoprotein levels or poorer liver function are at greatest risk of HCC, highlighting an unmet need for better risk stratification models.
引用
- Koo E, Seif El Dahan K, Daher D, et al. Risk of Hepatocellular Carcinoma in Subcentimeter Liver Nodules Identified on Surveillance Ultrasound: A Systematic Review. Clin Gastroenterol Hepatol. 2024. PMID: 39481466. doi:10.1016/j.cgh.2024.08.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。